Dr. Axe Wire · Study decoded · health

Weight-Loss Diets Shift 32 Blood Markers Tied to Metabolism

A review of 9 randomized trials found weight-loss diets altered 32 blood markers tied to inflammation, blood sugar and cholesterol regulation.

By Dr. Josh Axe · November 12, 2026 · 1 source · Understand

Photo: Pexels

At a glance

What they found: Weight-loss diets changed levels of 32 different blood markers that help switch genes on or off, across 9 independent trials.

Weight-loss diets change levels of 32 different circulating microRNAs, the small molecules that help control gene activity, according to a systematic review of 9 randomized trials published November 5, 2026.

32markers shifted

9trials, 6 countries

2-18month diets

5markers repeated

A systematic review gathered 12 articles representing 9 independent randomized trials across 6 countries, covering adults with overweight or obesity on weight-loss diets lasting 2 to 18 months. The researchers, writing in Nutrition Reviews, searched seven databases through May 2026 and screened 4,383 records to reach the final set. Across the trials, 32 distinct circulating microRNAs, small molecules that help switch genes on or off, changed with the diets. Five of them, miR-221-3p, miR-223, miR-99b, miR-122 and miR-128, were reported as changed in more than one trial, the strongest signal in the review. These microRNA changes were linked to weight loss itself and to body fat, blood sugar control, cholesterol, inflammation markers and cardiovascular risk markers across the trials.

Pathway analysis pointed to two signaling routes, PI3K-Akt and MAPK, that these microRNAs feed into; both help cells sense insulin and manage fat storage. The review's conclusion describes weight-loss diets as changing this microRNA profile, with potential influence on glycolipid metabolism and inflammation, and frames these molecules as candidate biomarkers rather than an established diagnostic or treatment target.

Circulating microRNAs act like dimmer switches for genes, travelling through blood to tell distant cells to ramp activity up or down. Five of the same switches moving in more than one independent trial despite very different diets points to a shared pathway that diet-driven weight loss touches beyond the scale number. Insulin signaling and fat metabolism were flagged most consistently.

Circulating MicroRNAs Changed By Weight-Loss Diets

Nutrition Reviews, 2026, Delmicon et al.

The 9 trials varied widely in diet type and length, 2 to 18 months, and the review did not isolate one diet pattern as responsible. These microRNA levels are a surrogate marker, not a measured disease outcome, so this does not yet show whether tracking them changes long-term health results.

Dr. Axe’s Take

Five of the same metabolic switches moving together across independent trials, including ones tied to insulin signaling and fat metabolism, tells me the body's internal chemistry responds to real dietary change within months, not just the number on the scale. This week I would build meals around fiber-rich vegetables, wild-caught fish and olive oil, the kind of anti-inflammatory eating pattern most likely to influence these same pathways, and pair it with a basic metabolic panel from your doctor to track blood sugar and cholesterol alongside the weight change.

— Dr. Axe

Take the Metabolic Health Quiz →

Study summary

Who: Adults with overweight or obesity across 9 independent randomized trials in 6 countries.
Design: Systematic review of 12 articles from 9 randomized clinical trials; risk of bias assessed with Cochrane RoB 2.0; PROSPERO CRD42024580048.
Dose: Weight-loss dietary interventions lasting 2 to 18 months; macronutrient composition varied widely across studies.
Primary result: 32 distinct circulating microRNAs were differentially expressed with weight-loss diets; 5 (miR-221-3p, miR-223, miR-99b, miR-122, miR-128) were reported in more than one study.
Secondary: MicroRNA changes were linked to weight loss, body fat, blood sugar control, cholesterol, inflammation and cardiovascular risk; pathway analysis flagged PI3K-Akt and MAPK insulin and fat-metabolism signaling routes.
Funding / conflicts: Funder listed in the journal record: São Paulo Research Foundation. Conflicts not reported in the abstract.
Date: Nov 5, 2026